A phase III trial of recombinant human growth hormone in pediatric patients with growth failure caused by chronic kidney disease
Hong Xu(Sichuan University), Haiping Yang(DigitalSpace (United States)), Jianjiang Zhang(First Affiliated Hospital of Zhengzhou University), Wenyan Huang, Ke Xu(Hubei University of Arts and Science), Yubing Wu, Chaoying Chen, Xiaoyan Fang, Cuihua Liu(National Institutes for Quantum Science and Technology), Xiaoshan Tang, Zhihong Lu, Fei Zhao(Zhejiang Chinese Medical University), Ping Wang(Xi'an Polytechnic University), Yufeng Li, Jing Chen(Guangdong Pharmaceutical University), Jingjing Wang(Heilongjiang Academy of Sciences), Xiuli Wang(Jilin University), Zhi Chen(Yangzhou University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Mo Wang(École Supérieure des Sciences Économiques et Commerciales), Aihua Zhang(Model Animal Research Center), Zihua Yu(Fujian Medical University), Liwen Sun, Yaju Zhu, Huijie Xiao(Beijing Forestry University), Qian Shen, Xiaojing Nie(Xian Central Hospital), Jun Huang(Ningbo No. 2 Hospital), Guanghai Cao, Jianhua Mao(Children's Hospital of Zhejiang University), Qiuxia Chen, Miao Wang(Harbin Electric Corporation (China)), Juan Tu(Collaborative Innovation Center of Advanced Microstructures)
Cited by 0
Related Papers
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
|Nature|2016|925
New developments in our understanding of acne pathogenesis and treatment
|Experimental Dermatology|2009|582
The relationship between cultural tightness–looseness and COVID-19 cases and deaths: a global analysis
|The Lancet Planetary Health|2021|535
GWASdb: a database for human genetic variants identified by genome-wide association studies
|Nucleic Acids Research|2011|233